3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Erectile Dysfunction
4
Pancreatic Neoplasms
3
Head and Neck Neoplasms
3
Neoplasms
2
Neoplasm Metastasis
2
Carcinoma
2
Adenocarcinoma
2
Urogenital Neoplasms
1
Urinary Incontinence
1
Sexual Dysfunction, Physiological
1
Pyridoxine-dependent epilepsy
1
Peripheral Nervous System Diseases
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neurotoxicity Syndromes
1
Multiple Myeloma
1
Mouth Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Glioblastoma
1
Gastric Adenocarcinoma
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Astrocytoma
1
Abdominal Cancer
1
Interventions
pembrolizumab
5
padeliporfin
5
Nivolumab
5
fludarabine
4
aldesleukin
4
Ipilimumab
4
Cyclophosphamide
4
atezolizumab
3
Specimen Handling
3
Paclitaxel
3
Magnetic Resonance Spectroscopy
3
Gemcitabine
3
Carboplatin
3
vedolizumab
2
olaparib
2
niraparib
2
motexafin gadolinium
2
cabozantinib
2
anlotinib
2
abiraterone
2
Therapeutics
2
Sunitinib
2
Standard of Care
2
Riluzole
2
Radiation Dose Hypofractionation
2
Prednisone
2
Pluvicto
2
Mitomycin
2
LDP-02
2
Infliximab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Urogenital Neoplasms
×
Tadalafil
×
Clear all
NCT06717711
2024-12-05
RCT_LiESWT
Regina Elena Cancer Institute
Phase 3
Recruiting
158 enrolled